Akari Therapeutics
Price & Volume
Stats
See moreOpen | $2.40 |
Previous Close | $2.42 |
Day Range | $2.40-$2.50 |
52W Range | $1.07-$4.40 |
Market Cap | $33.7M |
Shares Short | 18,456 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.99 |
News
See moreYahoo Finance • 12 months ago
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
Yahoo Finance • last year
Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
Yahoo Finance • last year
Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now
Yahoo Finance • last year
Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now
About
CEO | Dr. Samir Rashmikant Patel M.D. |
Address | 22 Boston Wharf Road, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
